Follow the 셀바스헬스케어 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 셀바스헬스케어 has logged 1 insider filings. Market capitalisation: €64.2bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: 한국증권금융. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Selvas Healthcare 是一家专注于医疗保健和制药领域的公司,在 XKRX 市场上市。它致力于开发创新的健康解决方案和医疗技术。